U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833813) titled 'Incretin Therapy and Exercise in Type 2 Diabetes' on Sept. 16.
Brief Summary: This study will examine changes in brain and physical health in adults with type 2 diabetes who are initiating incretin-mimetic therapy (e.g., Ozempic, Mounjaro), and determine whether adding structured exercise provides additional benefits. Participants will be randomized to receive incretin-mimetic therapy alone or incretin-mimetic therapy plus a structured exercise program for 24 weeks. If the participant is randomly assigned to the incretin-based therapy alone group, they will have the opportunity to complete the same structured exercise program after...